课题基金 / 基金详情

Identifying the pathological mechanism of polyalanine expansion mutations in the X-linked Hypopituitarism gene SOX3

Identifying the pathological mechanism of polyalanine expansion mutations in the X-linked Hypopituitarism gene SOX3
鉴定X连锁垂体功能减退症基因SOX3中多聚丙氨酸扩增突变的病理机制
批准号:
nhmrc : 465401
负责人:
Prof Paul Thomas
金额:
$26.86万
依托单位:
依托单位国家:
澳大利亚
项目类别:
NHMRC Project Grants
财政年份:
2007
资助国家:
澳大利亚
项目状态:
已结题
起止时间:
2007-01-01 至 2009-12-31

项目摘要

项目成果

Prof Paul Thomas的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Mental retardation (MR) is a debilitating disorder which affects 1-3% of the population. In many cases, MR results from changes (mutations) in genes which regulate the development of the brain before birth. We are studying families with an inherited form of MR termed X-linked Hypopituitarism (XH) in which only boys are affected. In addition to intellectual disability, boys with XH also have poor pituitary function resulting in short stature and slow metabolism. In severe cases, where the pituitary has failed to form completely, these babies are extremely ill and in some instances do not survive. We have previously shown that XH is due to an unusual change in the SOX3 gene in which the number of consecutive alanine residues is increased above a critical threshold (polyalanine expansion mutations). Similar mutations have recently been identified in several other genes that also cause severe birth defects. However, little is currently known about how polyalanine expansion mutations cause these disorders. The overall aim of this proposal is generate a mouse model for this disorder. Analysis of these mice will help us to answer many unresolved questions about this disorder including: How does the mutant protein cause this disorder? Which parts of the brain and pituitary are affected and how is their function altered? How does the mutant protein affect other genes and proteins in the cell? Ultimately, we hope that this mouse model will help us to develop new and improved therapies for XH and other disorders that are caused by alanine expansion mutations.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Development of genetic technology for rodent population suppression
  • 批准号:
    LP180100748
  • 项目类别:
    Linkage Projects
  • 资助金额:
    $34.82万
  • 财政年份:
    2020
  • 负责人:
    Prof Paul Thomas
  • 依托单位:
Development of efficient CRISPR gene drives in mice
  • 批准号:
    DP190102312
  • 项目类别:
    Discovery Projects
  • 资助金额:
    $29.16万
  • 财政年份:
    2019
  • 负责人:
    Prof Paul Thomas
  • 依托单位:
Genetic control of spermatogenesis: defining the role of SOX3 in spermatogonial progenitor cells
  • 批准号:
    DP140103965
  • 项目类别:
    Discovery Projects
  • 资助金额:
    $27.25万
  • 财政年份:
    2014
  • 负责人:
    Prof Paul Thomas
  • 依托单位:
Function and redundancy of SOX genes in the mammalian sex determination pathway
  • 批准号:
    DP0881509
  • 项目类别:
    Discovery Projects
  • 资助金额:
    $23.95万
  • 财政年份:
    2008
  • 负责人:
    Prof Paul Thomas
  • 依托单位:
国内基金
海外基金
生理/病理应激差异化调控肝再生的“蓝斑—中缝”神经环路机制
  • 批准号:
    82371517
  • 项目类别:
    面上项目
  • 资助金额:
    49.00万元
  • 批准年份:
    2023
  • 负责人:
    杨立群
  • 依托单位:
PRRC2在eIF3调控的翻译过程中的分子机制及其对肌肉健康的影响
  • 批准号:
    32100620
  • 项目类别:
    青年科学基金项目(C类)
  • 资助金额:
    30.0万元
  • 批准年份:
    2021
  • 负责人:
    林英英
  • 依托单位:
MitoNEET通过调控线粒体形态和功能减轻肾脏缺血再灌注损伤的作用及机制研究
  • 批准号:
    32100537
  • 项目类别:
    青年科学基金项目(C类)
  • 资助金额:
    30.0万元
  • 批准年份:
    2021
  • 负责人:
    齐元博
  • 依托单位:
直肠癌术前同期放化疗后pCR病例的筛选模型研究
  • 批准号:
    81071891
  • 项目类别:
    面上项目
  • 资助金额:
    10.0万元
  • 批准年份:
    2010
  • 负责人:
    高远红
  • 依托单位: